According to Zacks, “Ichor Holdings, Ltd. is engaged in the design, engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment. Ichor Holdings, Ltd. is based in Fremont, United States. “
A number of other analysts have also recently issued reports on ICHR. Northland Securities set a $13.00 target price on Nabriva Therapeutics and gave the stock a buy rating in a research note on Wednesday, May 8th. ValuEngine cut Zions Bancorporation NA from a hold rating to a sell rating in a research note on Wednesday, March 20th. B. Riley set a $7.00 target price on Unique Fabricating and gave the stock a buy rating in a research note on Thursday, May 16th. DA Davidson cut Advanced Energy Industries from a buy rating to a neutral rating and lowered their target price for the stock from $60.00 to $55.00 in a research note on Monday, July 8th. Finally, Cowen reaffirmed a buy rating and set a $149.00 price target on shares of Intercept Pharmaceuticals in a research report on Wednesday, May 8th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the stock. The stock has an average rating of Hold and an average price target of $27.38.
Ichor (NASDAQ:ICHR) last posted its earnings results on Tuesday, May 7th. The technology company reported $0.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.06). Ichor had a return on equity of 22.62% and a net margin of 6.07%. The business had revenue of $137.80 million for the quarter, compared to the consensus estimate of $135.39 million. During the same period in the previous year, the company posted $1.03 earnings per share. Ichor’s revenue for the quarter was down 46.6% compared to the same quarter last year. Analysts anticipate that Ichor will post 1.12 EPS for the current fiscal year.
A number of large investors have recently added to or reduced their stakes in ICHR. Crossmark Global Holdings Inc. acquired a new stake in Ichor in the second quarter valued at about $220,000. Kennedy Capital Management Inc. boosted its stake in Ichor by 4.6% in the first quarter. Kennedy Capital Management Inc. now owns 755,316 shares of the technology company’s stock valued at $17,055,000 after buying an additional 33,298 shares in the last quarter. Capital Management Associates NY acquired a new stake in Ichor in the first quarter valued at about $384,000. Globeflex Capital L P boosted its stake in shares of Ichor by 2.3% during the first quarter. Globeflex Capital L P now owns 57,863 shares of the technology company’s stock valued at $1,307,000 after purchasing an additional 1,307 shares in the last quarter. Finally, Royce & Associates LP boosted its stake in shares of Ichor by 21.1% during the first quarter. Royce & Associates LP now owns 646,924 shares of the technology company’s stock valued at $14,608,000 after purchasing an additional 112,532 shares in the last quarter. 94.27% of the stock is owned by hedge funds and other institutional investors.
Ichor Holdings, Ltd. engages in the design, engineering, and manufacture of fluid delivery subsystems and components for semiconductor capital equipment. It primarily offers gas and chemical delivery subsystems that are used in the manufacturing of semiconductor devices. The company's gas delivery subsystems deliver, monitor, and control gases used in semiconductor manufacturing processes, such as etch and deposition; and chemical delivery subsystems blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes comprising electroplating and cleaning.
Featured Article: Is a Roth IRA right for you?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ichor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ichor and related companies with MarketBeat.com's FREE daily email newsletter.